CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
暂无分享,去创建一个
Hanina Hibshoosh | Gidi Rechavi | Nadir Arber | M. Mansukhani | H. Hibshoosh | L. Memeo | N. Arber | J. Jacob-Hirsch | E. Sagiv | D. Kazanov | G. Rechavi | Lorenzo Memeo | Mahesh Mansukhani | Eyal Sagiv | Adi Karin | Diana Kazanov | Jasmin Jacob-Hirsch | Adi Karin | Gidi Rechavi
[1] H. Blum,et al. Molecular pathogenesis of colorectal cancer , 2005, Cancer.
[2] J. Morrow,et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.
[3] D. Figarella-Branger,et al. CD24, a glycosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors , 1996, Acta Neuropathologica.
[4] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[5] Thomas D. Wu,et al. Analysing gene expression data from DNA microarrays to identify candidate genes , 2001, The Journal of pathology.
[6] N. Kiyokawa,et al. CD24 Induces Apoptosis in Human B Cells Via the Glycolipid-Enriched Membrane Domains/Rafts-Mediated Signaling System1 , 2001, The Journal of Immunology.
[7] P. Altevogt,et al. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. , 2000, Cancer research.
[8] W. Weichert,et al. Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival , 2005, Clinical Cancer Research.
[9] R. Stahel,et al. Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. , 1996, Biochemical and biophysical research communications.
[10] G. Piazza,et al. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. , 1997, Gastroenterology.
[11] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] Z. Halpern,et al. Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus , 2001, Oncogene.
[13] C. Pilarsky,et al. Expression of CD24 in Adenocarcinomas of the Pancreas Correlates with Higher Tumor Grades , 2004, Pancreatology.
[14] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.
[15] N. Arber,et al. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins. , 2000, The Israel Medical Association journal : IMAJ.
[16] D. Haller,et al. Therapy for early-stage colorectal cancer. , 1999, Oncology.
[17] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[18] K. Seibert,et al. Advances in Brief Evaluation of Cyclooxygenase-2 Inhibitor for Potential Chemopreventive Properties in Colon Carcinogenesis ' , 2006 .
[19] Peter Altevogt,et al. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells , 2006, Journal of Cell Science.
[20] R. DuBois,et al. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. , 1996, Gastroenterology clinics of North America.
[21] Han-Woong Lee,et al. TCR-Independent and Caspase-Independent Apoptosis of Murine Thymocytes by CD24 Cross-Linking1 , 2004, The Journal of Immunology.
[22] I. Weinstein,et al. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. , 1996, Oncogene.
[23] P. Altevogt,et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.
[24] Robert Riddell,et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.
[25] P. Altevogt,et al. Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal transduction. , 1994, Biochemical and biophysical research communications.
[26] E. Hawk,et al. Development of COX Inhibitors in Cancer Prevention and Therapy , 2003, American journal of clinical oncology.
[27] S Jothy,et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.
[28] N. Arber,et al. Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cells in Vitro , 2004, Clinical Cancer Research.
[29] L. Distel,et al. CD24 promotes invasion of glioma cells in vivo. , 1999, Journal of neuropathology and experimental neurology.
[30] Y. Shin,et al. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. , 2005, Gynecologic oncology.
[31] Marc A Pfeffer,et al. Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention , 2005, The New England journal of medicine.
[32] Hideki Nakajima,et al. Pre-B Cell Antigen Receptor-Mediated Signal Inhibits CD24-Induced Apoptosis in Human Pre-B Cells1 , 2003, The Journal of Immunology.
[33] H. Hsu,et al. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. , 1995, Cancer research.
[34] G. Kristiansen,et al. Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule , 2003, Journal of Molecular Histology.
[35] O. Margalit,et al. Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines , 2003, British Journal of Cancer.
[36] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[37] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[38] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[39] S. Loening,et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer , 2004, The Prostate.
[40] C. Pilarsky,et al. CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.